Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agios Pharmaceuticals (AGIO) Divestments (2020 - 2021)

Historic Divestments for Agios Pharmaceuticals (AGIO) over the last 2 years, with Q1 2021 value amounting to $1.8 billion.

  • Agios Pharmaceuticals' Divestments rose 69621428.57% to $1.8 billion in Q1 2021 from the same period last year, while for Dec 2021 it was $1.8 billion, marking a year-over-year increase of 22462503.11%. This contributed to the annual value of $200.0 million for FY2024, which is N/A changed from last year.
  • Latest data reveals that Agios Pharmaceuticals reported Divestments of $1.8 billion as of Q1 2021, which was up 69621428.57% from -$455000.0 recorded in Q4 2020.
  • Over the past 5 years, Agios Pharmaceuticals' Divestments peaked at $1.8 billion during Q1 2021, and registered a low of -$455000.0 during Q4 2020.